news
Cala Health's TAPS therapy device gets TIME healthtech nod for 2026
Cala Health's TAPS therapy, a medical device for essential tremor, was named to TIME and Statista's World's Top HealthTech Companies 2026 list. This recognition evaluated financial performance, reputation, and online engagement across 500 healthtech firms. The device targets the nervous system to calm motor symptoms.
Cala Health's TAPS therapy, a medical device for essential tremor, was named to TIME and Statista's World's Top HealthTech Companies 2026 list. This recognition evaluated financial performance, reputation, and online engagement across 500 healthtech firms. The device targets the nervous system to calm motor symptoms.
The architecture take
TIME and Statista putting Cala Health's TAPS therapy on their healthtech list isn't just an award; it's a signal. The company's device uses transcutaneous afferent peripheral nerve stimulation (TAPS) to calm brain activity linked to essential tremor. That means it's working directly on the nervous system, sending tiny electrical pulses to peripheral nerves to modulate signals that cause involuntary movements. This isn't some vague wellness trend; it's a prescribed medical device targeting a specific neurological condition. When big publications start highlighting neurotech like this, it means the industry's moving past basic wearables and into more active, targeted therapies. Watch for more non-pharmacological interventions that aim to re-regulate brain states directly, especially for chronic conditions where medication side effects are a problem. The body knows how to self-correct; sometimes it just needs a precise nudge.